Literature DB >> 12791316

IL-1beta, IFN-gamma and TNF-alpha increase vulnerability of pancreatic beta cells to autoimmune destruction.

Gerhild Wachlin1, Petra Augstein, Dieter Schröder, Beate Kuttler, Ingrid Klöting, Peter Heinke, Siegfried Schmidt.   

Abstract

In the pathogenesis of type-1 diabetes insulin-producing beta-cells are destroyed by cellular autoimmune processes. The locality of beta-cell destruction is the inflamed pancreatic islet. During insulitis cytokines released from islet-infiltrating mononuclear cells affect beta-cells at several levels. We investigated whether cytokine-induced beta-cell destruction is associated with changes in the expression of the surface receptors intercellular adhesion molecule (ICAM)-1 and Fas. Islets from diabetes-prone and congenic diabetes-resistant BB rats were exposed to interleukin (IL)-1beta alone or in combination with interferon (IFN)-gamma plus tumour necrosis factor (TNF)-alpha. Cytokines decreased islet insulin content, suppressed glucose stimulated insulin secretion and generated enhanced amounts of nitric oxide and DNA-strand breaks. While no membrane alterations of IL-1beta treated islets cells were detectable, the cytokine combination caused damage of cell membranes. Independent of diabetes susceptibility IL-1beta treated islet beta-cells expressed a significantly increased amount of ICAM-1 on their surfaces which was not further increased by IFN-gamma+TNF-alpha. However, IL-1beta induced Fas expression was significantly enhanced only on beta-cells from diabetes-prone BB rats. From these results we suggest that IL-1beta mediates the major stimulus for ICAM-1 induction which is possibly a necessary but not sufficient step in the process of beta-cell destruction. Obviously, the additional enhancement of Fas expression on the surface of beta-cells is important for destruction. The combined action of all three cytokines induced the expression of Fas on the beta-cell surface independent of diabetes susceptibility, indicating that such a strong stimulus in vitro may induce processes different from the precise mechanisms of beta-cell destruction in vivo.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12791316     DOI: 10.1016/s0896-8411(03)00039-8

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  26 in total

1.  Quantification of basal and stimulated ROS levels as predictors of islet potency and function.

Authors:  B Armann; M S Hanson; E Hatch; A Steffen; L A Fernandez
Journal:  Am J Transplant       Date:  2007-01       Impact factor: 8.086

2.  Methylation of insulin DNA in response to proinflammatory cytokines during the progression of autoimmune diabetes in NOD mice.

Authors:  Jinxiu Rui; Songyan Deng; Jasmin Lebastchi; Pamela L Clark; Sahar Usmani-Brown; Kevan C Herold
Journal:  Diabetologia       Date:  2016-02-24       Impact factor: 10.122

Review 3.  Extracellular Vesicles in Type 1 Diabetes: Messengers and Regulators.

Authors:  Sarita Negi; Alissa K Rutman; Steven Paraskevas
Journal:  Curr Diab Rep       Date:  2019-07-31       Impact factor: 4.810

Review 4.  IL-17 and limits of success.

Authors:  Zahra Omidian; Rizwan Ahmed; Adebola Giwa; Thomas Donner; Abdel Rahim A Hamad
Journal:  Cell Immunol       Date:  2018-09-17       Impact factor: 4.868

5.  Roles of TNF-α, GSK-3β and RANKL in the occurrence and development of diabetic osteoporosis.

Authors:  Jun Qi; Ke-Su Hu; Hui-Lin Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

6.  NFAT targets signaling molecules to gene promoters in pancreatic β-cells.

Authors:  Michael C Lawrence; Nofit Borenstein-Auerbach; Kathleen McGlynn; Faisal Kunnathodi; Rauf Shahbazov; Ilham Syed; Mazhar Kanak; Morihito Takita; Marlon F Levy; Bashoo Naziruddin
Journal:  Mol Endocrinol       Date:  2014-12-12

7.  Antioxidant enzyme activity and mRNA expression in the islets of Langerhans from the BB/S rat model of type 1 diabetes and an insulin-producing cell line.

Authors:  Louise A Sigfrid; James M Cunningham; Neil Beeharry; L A Håkan Borg; Alma L Rosales Hernandez; Carina Carlsson; Adrian J Bone; Irene C Green
Journal:  J Mol Med (Berl)       Date:  2004-03-09       Impact factor: 4.599

8.  Adiponectin counteracts cytokine- and fatty acid-induced apoptosis in the pancreatic beta-cell line INS-1.

Authors:  I Rakatzi; H Mueller; O Ritzeler; N Tennagels; J Eckel
Journal:  Diabetologia       Date:  2004-01-13       Impact factor: 10.122

9.  Incomplete Killing And Enhanced Activation of Islet-Reactive CD8+ T Cells by FasL-Expressing Dendritic Cells Limits Protection from Diabetes.

Authors:  Mikael Maksimow; Catharina Alam; Arno Hänninen
Journal:  Rev Diabet Stud       Date:  2008-11-10

Review 10.  Neutralization Versus Reinforcement of Proinflammatory Cytokines to Arrest Autoimmunity in Type 1 Diabetes.

Authors:  Ayelet Kaminitz; Shifra Ash; Nadir Askenasy
Journal:  Clin Rev Allergy Immunol       Date:  2017-06       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.